Finance

Lists
BIO:NYSE
Bio-Rad Laboratories, Inc. Class A Common Stock
$361.19
-0.25%
(-0.89) 1D
$361.19
0.00% (0.00)
After hours
Closed: Aug 13, 4:00:08 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BIO...
Open
$364.00
High
$365.00
Low
$352.12
Mkt. cap
9.53B
Avg. vol.
297.99K
Volume
207.47K
P/E ratio
43.79
52-wk high
$365.00
52-wk low
$236.73
EPS
$8.25
Beta
1.06
Shares outstanding
21.68M
No. of employees
7K
Open
$364.00
High
$365.00
Low
$352.12
Mkt. cap
9.53B
Avg. vol.
297.99K
Volume
207.47K
P/E ratio
43.79
52-wk high
$365.00
52-wk low
$236.73
EPS
$8.25
Beta
1.06
Shares outstanding
21.68M
No. of employees
7K
News stories
From web sources and news partners
Profile
Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets. The company was founded in 1952 in Berkeley, California, by husband and wife team David and Alice Schwartz, both graduates of the University of California, Berkeley. Bio-Rad is based in Hercules, California, and has operations worldwide. Wikipedia
About Bio-Rad Laboratories, Inc. Class A Common Stock
CEONorman David Schwartz
Employees7.45K
Founded1952
HeadquartersHercules, California, United States
SectorHealth care
Websitebio-rad.com
Analyst ratings
Based on 4 analysts giving stock ratings to BIO in the past 3 months
Hold
Buy
1
Hold
3
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for BIO in the last 3 months.
Highest
Current $361.19
$390.00 (+7.98%)
Average
$331.25 (-8.29%)
Lowest
$275.00 (-23.86%)
Analyst
Recommendation
Action
Price target
Projected
Date
Dan Leonard
RBC Capital
Buy
Reiterated
$390.00
+8%
08/06/2026
Brandon Couillard
Wells Fargo
Hold
Reiterated
$330.00
-8.6%
08/05/2026
Daniel Grosslight
Citi
Hold
Maintained
$330.00
-8.6%
08/05/2026
Tycho Peterson
Jefferies
Hold
Maintained
$275.00
-23.9%
05/21/2026
Unknown Analyst
RBC Capital
Buy
Initiated
$320.00
-11.4%
05/14/2026
Patrick B Donnelly
Citi
Hold
Downgraded
$300.00
-16.9%
04/07/2026
Last report
Aug 4, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$2.62 / $1.75
+50.13%beat
Revenue / Est. (USD)
651.00M / 623.98M
+4.33%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
653.00M
693.20M
592.10M
651.00M
Cost of goods sold
310.20M
348.40M
282.70M
305.20M
Cost of revenue
310.20M
348.40M
282.70M
305.20M
Research and development expenses
70.60M
66.00M
62.90M
61.20M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
204.20M
217.30M
212.10M
211.80M
Operating expense
274.80M
283.30M
275.00M
273.00M
Total operating expenses
585.00M
631.70M
557.70M
578.20M
Operating income
68.00M
61.50M
34.40M
72.80M
Other non operating income
-600.00K
-600.00K
400.00K
600.00K
EBT including unusual items
-431.10M
929.20M
-689.80M
542.10M
EBT excluding unusual items
71.70M
81.90M
45.90M
83.80M
Income tax expense
-89.20M
209.20M
-162.70M
170.70M
Effective tax rate
20.69%
22.51%
23.59%
31.49%
Other operating expenses
-
-
-
-
Net income
-341.90M
720.00M
-527.10M
371.40M
Net profit margin
-52.36%
103.87%
-89.02%
57.05%
Earnings per share
2.26
2.51
1.89
2.62
Interest and investment income
13.70M
31.00M
21.00M
22.30M
Interest expense
-12.30M
-12.10M
-12.30M
-12.10M
Net interest expenses
1.40M
18.90M
8.70M
10.20M
Depreciation and amortization charges
-
-
-
-
EBITDA
112.20M
104.00M
75.30M
113.90M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps